Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system
SweetSpot partners with endocrinology practices to provide virtual CGM monitoring and enhanced patient care
GERMANTOWN, Md. and PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE: SENS) and Ascensia Diabetes Care announce the software integration of SweetSpot™ with the Eversense® 365 Continuous Glucose Monitoring (CGM) System in the U.S. This software integration provides endocrinology practices that partner with SweetSpot the ability to continue to improve patient care by seamlessly and regularly reviewing data from patients using Eversense 365, the world's first and only One Year CGM.
SweetSpot combines a centralized software platform for managing diabetes device data with wrap-around clinical support services. SweetSpot’s virtual team of Certified Diabetes Care and Education Specialists (CDCES) perform monthly CGM data reviews and coordinate with providers and patients on treatment plan assessment and changes. By developing an integration with Eversense 365, SweetSpot can work alongside practices to act on this unique system’s CGM data in between patients’ scheduled appointments, allowing for more personalized support. These regular data reviews help ensure patients get timely treatment adjustments, keeping them better connected to their diabetes care team year-round with a goal of improving glycemic control. Practices can also unlock new opportunities through SweetSpot’s automated capture of reimbursable care events, making partnering with SweetSpot both clinically impactful and operationally efficient.
Read the full release here: https://www.senseonics.com/investor-relations/news-releases/2025/02-26-2025-123111161